BioHarvest Sciencesの空売り状況は、投資家がBioHarvest Sciencesの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

BioHarvest Sciences (NASDAQ:BHST) 株価情報, 空売り情報

BioHarvest Sciences

BioHarvest Sciences Inc. - Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences Inc

News

Zomedica Reports Transition To OTCQB Venture Market, Common Shares To Be Delisted From NYSE American Exchange

Carlisle Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) has outperformed the market over the past 5 years by 2.48% on an annualized basis producing an average annual return of 18.51%. Currently, Carlisle Companies has a market capitalization of $14.56 billion. 
Buying $1000 In CSL: If an investor had bought $1000 of CSL stock 5 years ago, it would be worth $2,266.80 today based on a price of $326.85 for CSL at the time of writing.
<h3>Carlisle Companies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741129214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Carlisle Companies 5 Years Ago Would Be Worth This Much Today

Loop Capital analyst Alton Stump maintains FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAT#NASDAQ">FAT</a>) with a Buy and lowers the price target from $15 to $12.

Price Target

Analyst Ratings

Loop Capital Maintains Buy on FAT Brands, Lowers Price Target to $12

Loop Capital analyst Jeffrey Stevenson maintains Installed Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) with a Buy and lowers the price target from $230 to $215.

Loop Capital Maintains Buy on Installed Building Prods, Lowers Price Target to $215

Jefferies analyst Jonathan Matuszewski maintains Best Buy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) with a Buy and lowers the price target from $106 to $92.

Jefferies Maintains Buy on Best Buy Co, Lowers Price Target to $92

Jefferies analyst Thomas Chong maintains Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) with a Buy and raises the price target from $131 to $157.

Jefferies Maintains Buy on Sea, Raises Price Target to $157

Jefferies analyst Corey Tarlowe maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Buy and lowers the price target from $165 to $150.

Jefferies Maintains Buy on Target, Lowers Price Target to $150

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has outperformed the market over the past 20 years by 2.01% on an annualized basis producing an average annual return of 10.16%. Currently, JPMorgan Chase has a market capitalization of $704.73 billion. 
Buying $100 In JPM: If an investor had bought $100 of JPM stock 20 years ago, it would be worth $688.26 today based on a price of $252.04 for JPM at the time of writing.
<h3>JPMorgan Chase's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741128309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In JPMorgan Chase 20 Years Ago Would Be Worth Today

Janney Montgomery Scott analyst Thomas Meric downgrades Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) from Buy to Neutral and announces $1 price target.

Downgrades

NOVA

Janney Montgomery Scott Downgrades Sunnova Energy Intl to Neutral, Announces $1 Price Target

The transaction is subject to regulatory approval and is expected to close during the second quarter of 2025.
Woodruff Sawyer&nbsp;pro forma revenues and EBITDAC (including expected synergies) for the trailing 12 months ended December 31, 2024 were approximately $268 million and $88 million, respectively.
Integration costs and expected non-cash management retention costs are expected to total $150 million over the next 3 years.
&nbsp;

Arthur J. Gallagher Agrees To Acquire San Francisco, California-based Woodruff Sawyer For Consideration Of $1.2B

DA Davidson analyst Manuel Navas initiates coverage on Eagle Financial Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSI#NASDAQ">EFSI</a>) with a Buy rating and announces Price Target of $40.

Initiation

EFSI

DA Davidson Initiates Coverage On Eagle Financial Services with Buy Rating, Announces Price Target of $40

Buybacks

AAON

AAON Board Approves $30M Of Share Repurchases Pursuant To Recently Disclosed $100M Share Repurchase Program

DA Davidson analyst Peter Heckmann maintains Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) with a Buy and lowers the price target from $14 to $12.

RPAY

DA Davidson Maintains Buy on Repay Holdings, Lowers Price Target to $12

Compass Point analyst Casey Alexander upgrades Acushnet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) from Neutral to Buy and raises the price target from $77 to $80.

Upgrades

GOLF

Compass Point Upgrades Acushnet Hldgs to Buy, Raises Price Target to $80

US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) has outperformed the market over the past 5 years by 2.96% on an annualized basis producing an average annual return of 19.0%. Currently, US Foods Hldg has a market capitalization of $15.73 billion. 
Buying $1000 In USFD: If an investor had bought $1000 of USFD stock 5 years ago, it would be worth $2,180.83 today based on a price of $68.26 for USFD at the time of writing.
<h3>US Foods Hldg's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741127426_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

USFD

Here's How Much You Would Have Made Owning US Foods Hldg Stock In The Last 5 Years

CIBC analyst Robert Catellier maintains Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) with a Neutral and raises the price target from $56 to $57.

CIBC Maintains Neutral on Williams Companies, Raises Price Target to $57

WGRX

Wellgistics Health CEO Tim Canning To Depart; Brian Norton Appointed As CEO

Canaccord Genuity analyst Joseph Vafi maintains Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) with a Buy and raises the price target from $120 to $130.

DAVE

Canaccord Genuity Maintains Buy on Dave, Raises Price Target to $130

S&amp;P 500 constituent Emerson Electric is acquiring Aspen Technology in a deal expected to be completed soon, pending final closing conditions.

AZPN

Albertsons Companies To Replace Aspen Technology In S&P MidCap 400, Effective Prior To  Opening Of Trading On March 11

CIBC analyst Scott Fletcher initiates coverage on Colliers International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGI#NASDAQ">CIGI</a>) with a Outperformer rating and announces Price Target of $160.

Comments

BioHarvest Sciences

空売り

BioHarvest Sciences (NASDAQ:BHST) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル